Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Seminars in Vascular Medicine|October 13, 2004
Factors affecting plasma lipoprotein(a) levels: role of hormones and other nongenetic factorsKaram M Kostner, Gert M KostnerDrug News & Perspectives|April 5, 2003
The Physiological Role of Lipoprotein (a)Karam M. Kostner, Gert M. KostnerJournal of Lipid Research|November 9, 2016
Lipoprotein (a): a historical appraisalKaram M Kostner, Gert M KostnerAtherosclerosis|May 11, 2018
Is Lp(a) ready for prime time use in the clinic? A pros-and-cons debateKaram M Kostner, Gert M Kostner, Anthony S WierzbickiBiochemistry|January 10, 2002
Solution structure of human apolipoprotein(a) kringle IV type 6Bernhard Maderegger, Wolfgang Bermel, Andelko Hrzenjak, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2012
FGF19 signaling cascade suppresses APOA gene expressionIndumathi Chennamsetty, Thierry Claudel, Karam M Kostner, et al.The Biochemical Journal|September 27, 2003
Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolismAndelko Hrzenjak, Sasa Frank, Xingde Wo, et al.Journal of Lipid Research|November 5, 2003
Defective uptake of triglyceride-associated fatty acids in adipose tissue causes the SREBP-1c-mediated induction of lipogenesisElke M Wagner, Dagmar Kratky, Guenter Haemmerle, et al.The Biochemical Journal|August 8, 2002
Endothelial cell-derived lipase mediates uptake and binding of high-density lipoprotein (HDL) particles and the selective uptake of HDL-associated cholesterol esters independent of its enzymic activityJuliane G Strauss, Robert Zimmermann, Andelko Hrzenjak, et al.The Journal of Clinical Investigation|August 2, 2011
Farnesoid X receptor represses hepatic human APOA gene expressionIndumathi Chennamsetty, Thierry Claudel, Karam M Kostner, et al.Pageof 2